EN DE
STOCK COMPARISON

Evotec vs Merck KGaA: Fair Value & Quality

Both stocks run through our valuation models. Here is how Evotec (EVT) and Merck KGaA (MRK) compare, as of Sep 27, 2026.

As of Sep 27, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Evotec trades at €2.81 versus a fair value of €1.92 (-32%), while Merck KGaA trades at €135 versus €109 (-19%).
Evotec
EVT.XETRA · EUR · Health Care
-32%
upside to fair value
overvalued
Price€2.81
Fair Value€1.92
Quality41/100
Merck KGaA
MRK.XETRA · EUR · Health Care
-19%
upside to fair value
overvalued
Price€135
Fair Value€109
Quality62/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

EvotecMerck KGaA
Valuation
n/aP/E (TTM)24.6×
n/aForward P/E (FY2026)16.0×
0.93×P/S (TTM)3.16×
0.86×P/B2.34×
n/aEV/EBITDA13.3×
1.43×PEG2.15×
−31.7%Fair value upside−19.3%
n/aDividend yield1.6%
n/aDividend per share€2.20
Profitability
-30%Operating margin14%
n/aEBIT margin trend (5Y)1.07×
-24%Return on equity8%
-3%Return on assets5%
Growth
-22%Revenue growth (YoY)3%
1.6%Avg. growth/yr (3Y)-1.7%
9.5%Avg. growth/yr (5Y)3.8%
n/aValue creation/yr+7.2%
Balance & size
n/aInterest coverage (EBIT/interest)15.5×
0.42×Debt / equity0.36×
$696MMarket cap$67B
expensiveGrowth qualitymixed

Even match: 5 to 5 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Evotecof which business quality 41 · market factors 6 Merck KGaAof which business quality 61 · market factors 67
ProfitabilityMargins and returns on capital today
6
41
Quality GrowthAre margins and returns improving?
54
40
CashflowEarnings quality: real cash, not paper profit
4
57
Fin. StrengthBalance sheet, leverage, solvency risk
54
75
InvestmentDisciplined investing over empire-building
87
80
Low VolatilityCalm price path (market factor)
20
73
MomentumPrice trend over the last 3–12 months (market factor)
0
61
52W MomentumDistance to the 52-week high (market factor)
1
70
Net IssuanceShare count: buybacks or dilution?
80
82

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyEvotecPrice €2.81Merck KGaAPrice €135
DCF Modelsn/a-21%below the price€107
Earnings-Basedn/a-61%below the price€53.25
Dividend Discountn/a-70%below the price€40.71
Multiplesn/a-12%close to the price€118
Asset-Based+9%close to the price€3.07-67%below the price€44.06
Growth DCFn/a-30%below the price€94.57
Economic Profitn/a-51%below the price€66.44
Growth Earningsn/a-15%close to the price€115
Minimum+9%close to the price€3.07-70%below the price€40.71
Maximum+9%close to the price€3.07-12%close to the price€118
Median+9%close to the price€3.07-40%below the price€80.50
Geometric mean+9%close to the price€3.07-45%below the price€73.75

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Evotec: 0 of 1 models see the stock below the current price.

Merck KGaA: 23 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Evotec
Price €2.81
Fair Value €1.92
Bear €1.44Bull €2.87
Merck KGaA
Price €135
Fair Value €109
Bear €60.04Bull €150

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Evotec · Health Care

Quality score41 · below median
Fair value upside-32% · below median

Merck KGaA · Health Care

Quality score62 · above median
Fair value upside-19% · above median

Bottom line

As of Sep 27, 2026, Fair Value Calculator sees Merck KGaA as the less overvalued of the two: Evotec trades at €2.81 versus a fair value of €1.92 (-32%), while Merck KGaA trades at €135 versus €109 (-19%).

Merck KGaA has the higher quality score (62/100).

Open Merck KGaA live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.